Position in BMY
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$5,591,271
-$50,452 QoQ
Shares Held
97,037
+4.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.80%
of 13F equity value
Holder Rank
#519
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 16%
Shared 0%
None 84%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Derivatives in BMY
reported options exposure · as of Mar 31, 2024CallValue
$21,692
CallShares
400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TOTH FINANCIAL ADVISORY CORP holds $48,675,880 across 11 Drug Manufacturers - General names. BMY ranks #4 (11.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
63,494 | $16,125,571 | |
| 2 | ABBV |
AbbVie Inc.
|
59,705 | $15,024,166 | |
| 3 | AMGN |
Amgen Inc
|
28,421 | $10,291,812 | |
| 4 | BMY |
Bristol Myers Squibb Co
This page
|
97,037 | $5,591,271 | |
| 5 | LLY |
ELI LILLY & Co
|
1,207 | $1,447,712 | |
| 6 | PFE |
Pfizer Inc
|
4,200 | $101,136 | |
| 7 | MRK |
Merck & Co., Inc.
|
539 | $69,261 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
117 | $14,781 |
All Filings in BMY
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,591,271 | 97,037 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $5,641,723 | 93,021 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $3,883,086 | 71,989 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $3,079,608 | 68,284 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $3,776,338 | 81,580 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $5,580,341 | 91,496 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $4,129,898 | 73,018 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $2,947,989 | 56,977 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $2,128,744 | 51,258 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $3,075,057 | 56,704 | Shares | Sole | 2024-04-16 | |
| 2024-03-31 | $21,692 | 400 | Call | Sole | 2024-04-16 | |
| 2023-12-31 | $2,741,955 | 53,439 | Shares | Sole | 2024-01-26 | |
| 2023-12-31 | $5,131 | 100 | Call | Sole | 2024-01-26 | |
| 2023-09-30 | $4,790,157 | 82,532 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $5,965,895 | 93,290 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $6,688,137 | 96,496 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $7,277,310 | 101,144 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $7,109 | 100 | Call | Sole | 2022-10-14 | |
| 2022-09-30 | $7,748,810 | 109,000 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $7,889,189 | 102,457 | Shares | Sole | 2022-07-25 | |
| 2022-06-30 | $7,700 | 100 | Call | Sole | 2022-07-25 | |
| 2022-03-31 | $6,666,762 | 91,288 | Shares | Sole | 2022-04-26 | |
| 2022-03-31 | $7,303 | 100 | Call | Sole | 2022-04-26 | |
| 2021-12-31 | $6,235 | 100 | Call | Sole | 2022-01-31 | |
| 2021-12-31 | $4,406,461 | 70,673 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $4,670,228 | 78,929 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $5,111,730 | 76,500 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $4,644,600 | 73,572 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $4,314,372 | 69,553 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $3,566,635 | 59,158 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $2,569,677 | 43,702 | Shares | Sole | 2020-07-14 | |
| 2020-03-31 | $231,209 | 4,148 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||